达仁堂：关于分公司获得药品注册证书的公告

Group 1 - The core announcement is that Darentang's subsidiary, Tianyao Darentang Group Co., Ltd., has received the drug registration certificate for Loxoprofen Sodium Gel Patch from the National Medical Products Administration [2] - This approval signifies a regulatory milestone for the company, potentially enhancing its product portfolio in the pharmaceutical market [2] - The Loxoprofen Sodium Gel Patch is expected to contribute to the company's revenue growth and market presence in the pain relief segment [2]